Life,
Год журнала:
2023,
Номер
13(8), С. 1757 - 1757
Опубликована: Авг. 16, 2023
Stress
is
a
process
that
triggers
various
physiological,
hormonal
and
psychological
mechanisms
in
response
to
threat,
which
significantly
affects
the
health
of
an
individual.
The
COVID-19
pandemic
introduced
lot
social
changes
required
constant
adaptation
unfavorable
conditions.
aim
study
was
assess
impact
stress
related
this
on
pregnant
women,
mothers
premature
infants
their
families,
obstetric
complications,
particularly
preterm
birth.
A
comprehensive
literature
review
performed
using
electronic
databases
such
as
Pubmed,
Science
Direct
Google
Scholar.
Keywords
as:
“prematurity”;
“pregnancy”;
“stress”;
“COVID-19”
combinations
above
were
used.
Maternal
anxiety
increase
levels
corticotropin-releasing
hormone
(CRH)
placenta,
turn
incidence
birth
many
other
maternal
neonatal
complications.
In
addition,
it
found
SARS-CoV-2
infection
may
risk
phenomenon.
has
adversely
affected
rates
mental
infants,
exacerbating
negative
experience
having
baby.
More
research
needed
demonstrate
long-term
effects
prematurity.
Biomedicines,
Год журнала:
2025,
Номер
13(2), С. 282 - 282
Опубликована: Янв. 24, 2025
Introduction:
The
emergence
of
the
SARS-CoV-2
virus
and
its
subsequent
global
pandemic
have
raised
significant
concerns
regarding
impact
on
pregnancy
outcomes.
This
review
aims
to
summarize
emerging
data
risk
preterm
delivery
in
pregnant
women
infected
with
SARS-CoV-2.
Materials
Methods:
A
systematic
search
was
conducted
from
March
2020
December
2023
using
PubMed
Web
Science,
following
PRISMA
guidelines.
Studies
correlating
maternal
COVID-19
infection
birth
were
included.
Results:
Thirteen
studies
analyzed,
indicating
a
higher
incidence
SARS-CoV-2-positive
compared
controls.
average
rate
patients
18.5%,
median
12.75%,
while
non-infected
showed
an
10%,
8.2%.
Discussion:
suggest
association
between
during
increased
cesarean
section.
severity
symptoms
underlying
comorbidities
further
elevate
this
risk.
Notably,
infections
third
trimester
pose
highest
birth.
Conclusion:
Preventing
is
crucial
mitigate
adverse
obstetric
Close
monitoring
tailored
interventions
for
women,
particularly
those
later
trimesters
comorbidities,
are
imperative
reduce
improve
maternal-fetal
BACKGROUND
AND
OBJECTIVES
COVID-19
vaccination
is
recommended
during
pregnancy;
however,
evidence
on
the
prevalence
of
major
structural
birth
defects
born
to
people
vaccinated
early
in
pregnancy
(≤20
weeks
gestation)
limited.
We
compared
by
status
and
key
strata:
insurance
provider,
clinically
diagnosed
SARS-CoV-2
infection
pregnancy,
concomitant
administration
other
maternal
vaccines.
also
compared,
head-to-head,
brand
(Moderna
mRNA-1273
vs
Pfizer-BioNTech
BNT162b2).
METHODS
A
claims-based
cohort
study
captured
pregnancies
ending
a
live
among
with
an
estimated
last
menstrual
period
between
August
15,
2021,
December
24,
2021.
Prevalence
ratios
comparing
exposure
vaccines
were
using
binomial
regression
inverse
probability
treatment
weights.
RESULTS
Among
78
052
pregnancies,
we
identified
1248
(1049
[160.6
per
10
000
births]
unvaccinated
199
[156.4
people).
No
differences
observed
given
(adjusted
ratio
[aPR],
0.96;
95%
CI,
0.81–1.13).
Findings
unchanged
(aPR,
1.02;
0.77–1.37).
CONCLUSIONS
not
associated
increased
infants.
These
results
support
safety
pregnancy.
BJOG An International Journal of Obstetrics & Gynaecology,
Год журнала:
2022,
Номер
130(4), С. 348 - 357
Опубликована: Ноя. 29, 2022
There
are
limited
data
regarding
COVID-19
vaccination
during
pregnancy.To
evaluate
the
effects
of
received
pregnancy
on
SARS-CoV-2
infection,
COVID-19-related
hospitalisation,
intensive
care
unit
(ICU)
admission
and
maternal-fetal
complications.MEDLINE,
CINHAL,
Embase,
Scopus
CENTRAL
databases,
as
well
ClinicalTrials.gov,
reference
lists,
related
articles
grey
literature
sources.Randomised
controlled
trials,
non-randomised
studies
interventions,
pregnant
women,
pregnancy.Study
selection,
risk-of-bias
assessment,
extraction
assessment
certainty
evidence
using
GRADE
method
were
performed
independently
by
two
authors.
Meta-analyses
Cochrane
RevMan
5.4.
PROSPERO
registration
number:
CRD42022308849.We
included
14
observational
(362
353
women).
The
administration
a
vaccine
resulted
in
statistically
significant
reduction
infection
(OR
0.46,
95%
CI
0.28-0.76)
hospitalisation
0.41,
0.33-0.51).
effect
appeared
to
be
greater
fully
vaccinated
for
both
0.31,
0.16-0.59)
0.15,
0.10-0.21).
However,
was
very
low.
difference
ICU
between
unvaccinated
individuals
did
not
reach
statistical
significance
0.58,
0.13-2.58).
Finally,
there
no
differences
any
complications
considered
studies.COVID-19
administered
seems
reduce
with
complications.
Obstetrics & Gynecology Science,
Год журнала:
2023,
Номер
66(4), С. 270 - 289
Опубликована: Май 17, 2023
The
coronavirus
disease
2019
(COVID-19)
outbreak
which
started
in
December
rapidly
developed
into
a
global
health
concern.
Pregnant
women
are
susceptible
to
respiratory
infections
and
can
experience
adverse
outcomes.
This
systematic
review
meta-analysis
compared
pregnancy
outcomes
according
COVID-19
status.
MEDLINE,
EMBASE,
Cochrane
Library
databases
were
searched
for
relevant
articles
published
between
1,
2019,
October
19,
2022.
Main
inclusion
criterion
was
any
population-based,
cross-sectional,
cohort,
or
case-control
study
that
assessed
with
without
laboratory-confirmed
COVID-19.
Sixty-nine
studies
including
1,606,543
pregnant
(39,716
[2.4%]
diagnosed
COVID-19)
retrieved.
COVID-19-infected
had
higher
risk
of
preterm
birth
(odds
ratio
[OR],
1.59;
95%
confidence
interval
[CI],
1.42-1.78),
preeclampsia
(OR,
1.41;
CI,
1.30-1.53),
low
weight
1.52;
1.30-1.79),
cesarean
delivery
1.20;
1.10-1.30),
stillbirth
1.71;
1.39-2.10),
fetal
distress
2.49;
1.54-4.03),
neonatal
intensive
care
unit
admission
2.33;
1.72-3.16),
perinatal
mortality
1.96;
1.15-3.34),
maternal
6.15;
3.74-10.10).
There
no
significant
differences
total
miscarriage,
premature
rupture
membranes,
postpartum
hemorrhage,
cholestasis,
chorioamnionitis
infection.
demonstrates
infection
during
lead
information
could
aid
researchers
clinicians
preparing
another
pandemic
caused
by
newly
discovered
viruses.
findings
this
may
assist
evidence-based
counseling
help
manage
Abstract
Vaccines
against
COVID-19
and
influenza
can
reduce
the
adverse
outcomes
caused
by
infections
during
pregnancy,
but
vaccine
uptake
among
pregnant
women
has
been
suboptimal.
We
examined
disparities
in
pandemic
to
inform
vaccination
interventions.
used
data
from
Oxford-Royal
College
of
General
Practitioners
Research
Surveillance
Centre
database
England
Secure
Anonymised
Information
Linkage
Databank
Wales.
The
at
least
one
dose
was
40.2%
for
41.8%
eligible
women.
observed
uptake,
with
socioeconomically
deprived
ethnic
minority
groups
showing
lower
rates.
suboptimal
vaccines,
especially
those
backgrounds
Black,
mixed
or
other
groups,
underscores
necessity
interventions
hesitancy
enhance
acceptance
BMC Pregnancy and Childbirth,
Год журнала:
2024,
Номер
24(1)
Опубликована: Авг. 29, 2024
Given
that
viral
infections
can
increase
the
risk
of
adverse
pregnancy
outcomes,
such
as
spontaneous
miscarriage,
preterm
premature
rupture
membranes,
and
birth,
effects
COVID-19,
a
novel
emerging
coronavirus
disease
rapidly
spreading
globally,
on
outcomes
have
garnered
significant
attention.
We
conducted
review
studies
related
to
pregnant
women
infected
with
SARS-CoV-2
over
past
five
years
(December
2019
April
2023),
utilizing
search
engines
PubMed,
Web
Science,
China
National
Knowledge
Infrastructure
(CNKI).
This
study
was
registered
PROSPERO
ID:
CRD42024540849.
A
total
218
articles
were
screened,
15
meeting
inclusion
criteria
for
this
research,
including
12
cohort
studies,
one
cross-sectional
study,
case-control
case
series.
Six
found
birth
rate
higher
in
group
compared
control
group;
showed
cesarean
section
three
APGAR
scores
newborns
than
indicated
mortality
group.
Our
retrospective
suggests
not
SARS-CoV-2,
those
diagnosed
COVID-19
are
more
likely
experience
delivery,
low
weight
newborns.
Annals of Medicine,
Год журнала:
2023,
Номер
55(2)
Опубликована: Сен. 27, 2023
Although
vaccination
with
the
Coronavirus
disease
2019
vaccine
is
important
and
effective
in
prevention
of
SARS-CoV-2
infection,
public
expressed
concerns
regarding
adverse
effects
on
fertility.
Some
reviews
have
focused
it,
they
been
unable
to
collect
sufficient
research
data
because
earlier
publication
period.
As
relevant
evidence
has
gradually
increased,
we
reviewed
these
studies
from
perspectives
males,
females
or
without
pregnancy,
different
types.
The
results
suggest
that
although
males
may
experience
fluctuations
semen
parameters
within
their
physiological
ranges
after
receiving
vaccine,
it
not
yet
reached
a
level
influence
partner's
pregnancy
probability.
female
believed
will
affect
fertility;
however,
more
needed
explore
short-term
impact.
Vaccination
during
any
trimester
considered
safe
pregnant
women.
The Journal of Dermatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 12, 2025
Atopic
dermatitis
(AD)
is
a
common
chronic
inflammatory
skin
condition.
COVID-19,
novel
coronavirus,
sparked
global
pandemic
in
late
2019.
The
connection
between
AD
and
COVID-19
infection
remains
unclear;
moreover,
the
risk
factors
for
among
patients
have
not
been
thoroughly
explored.
TriNetX
Research
Network
was
used
to
investigate
association
infection.
A
logistic
regression
estimate
odds
ratio
(OR)
We
found
that
had
significantly
higher
of
compared
individuals
without
AD,
regardless
age
sex.
For
patients,
we
younger
group
(age
≤
20
years)
lower
when
with
old-age
groups,
while
no
significant
difference
females
males
observed.
Hypertension,
diabetes
mellitus,
asthma,
ischemic
heart
disease,
overweight
obesity
increased
infection,
respectively.
treated
by
dupilumab
resulted
those
methylprednisolone,
prednisone,
or
prednisolone.
In
conclusion,
across
all
groups
sexes.
Younger
demonstrated
risks.
Certain
comorbidities
further
patients.
Treatment
associated